A functional comparison of recombinant and native somatostatin sst 2 receptor variants in epithelia

British Journal of Pharmacology

Volumn 152, Issue 1, 2007, Pages 132-140

  Holliday, N D ^a   Tough, I R ^a   Cox, H M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epithelial ion transport; Somatostatin 2 receptor variants; Sst 2a; Sst 2b

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BIM 23027; BIM 23190C; BIM 23268; CYN 154806; DEXTRO PHENYLALANYLPHENYLALANYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLPHENYLALANYL DEXTRO [3 (2 NAPHTHYL)ALANINAMIDE]; RECEPTOR BLOCKING AGENT; SOMATOSTATIN; SOMATOSTATIN 14; SOMATOSTATIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DESENSITIZATION; DRUG EFFECT; ELECTROPHYSIOLOGY; EPITHELIUM; HUMAN; ION TRANSPORT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CELL LINE, TUMOR; COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; HUMANS; INTESTINAL MUCOSA; MALE; MEMBRANE POTENTIALS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PHOSPHORYLATION; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; RECOMBINANT PROTEINS; SOMATOSTATIN; TIME FACTORS; TRANSFECTION;

EID: 34548348799     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707365     Document Type: Article

References (43)

1. 2(b) receptor isoforms mediate opposite effects on cell proliferation. Br J Pharmacol 125: 1630-1633.
2. Allen JP, Canty AJ, Schulz S, Humphrey PPA, Emson PC, Young HM (2002). Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of sstr2 knockout/lacZ knockin mice. J Comp Neurol 454: 329-340.
3. Alumets J, Sundler F, Håkanson R (1977). Distribution, ontogeny and ultra-structure of somatostatin-immunoreactive cells in the pancreas and the gut. Cell Tissue Res 185: 465-479.
4. Beau I, Groyer-Picard MT, Desroches A, Condamine E, Leprince J, Tome JP et al. (2004). The basolateral sorting signals of the thyrotropin and luteinizing hormone receptors: an unusual family of signals sharing an unusual distal intracellular localization, but unrelated in their structures. Mol Endocrinol 18: 733-746.
5. Breeman WA, de Jong M, Kwekkeboom DJ, Valkema R, Bakker WH, Koojj PP et al. (2001). Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives. Eur J Nucl Med 28: 1421-1429.
6. 2 receptor splice variants. J Physiol 94: 217-237.
7. Cox HM, Cuthbert AW, Håkanson R, Wahlestedt C (1988). The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol 398: 65-80.
8. 4 receptor expression in human colonic adenocarcinoma cell lines. Br J Pharmacol 132: 345-353.
9. Ekblad E, Ekman R, Håkanson R, Sundler F (1988). Projections of peptide-containing neurons in rat colon. Neuroscience 27: 655-674.
10. Eklund S, Sjöqvist A, Fahrenkrug J, Jodal M, Lundgren O (1988). Somatostatin and met-enkephalin inhibit cholera toxin-induced jejunal net fluid secretion and release VIP in the cat in vivo. Acta Physiol Scand 133: 551-557.
11. Elberg G, Hipkin RW, Schonbrunn A (2002). Homologous and heterologous regulation of somatostatin receptor 2. Mol Endocinol 16: 2502-2514.
12. 2 receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39: 1443-1450.
13. Ferrar JA, Cuthbert AW, Cox HM (1990). The antisecretory effects of somatostatin and analogues in rat descending colon mucosa. Eur J Pharmacol 184: 295-303.
14. 2A receptors in human gastrointestinal tissue. Gut 53: 1431-1436.
15. Hicks GA, Feniuk W, Humphrey PPA (1998). Outward current produced by somatostatin (SRIF) in rat anterior cingulated pyramidal cells in vitro. Br J Pharmacol 124: 252-258.
16. Hipkin RW, Wang Y, Schonbrunn A (2000). Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor. J Biol Chem 275: 5591-5599.
17. Hofland LJ, Lamberts SWJ (2003). The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocrinol Rev 24: 28-47.
18. 1 receptor desensitisation and internalisation. Mol Pharmacol 67: 655-664.
19. Kleuss C, Hescheler J, Ewel C, Rosenthal W, Schultz G, Wittig B (1991). Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 353: 43-48.
20. Knobloch SF, Diener M, Rummel W (1989). Antisecretory effects of somatostatin and vasopressin in the rat colon descendens in vitro. Reg Peptides 25: 75-85.
21. Lamberts SWJ, van der Lely A, de Herder WW, Hofland LJ. (1996). Octreotide. Drug therapy. New Engl J Med 334: 246-254.
22. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi J-C, Schonbrunn A (2005). Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68: 90-101.
23. Liu Q, Reubi J-C, Wang Y, Knoll BJ, Schonbrunn A (2003). In vivo phosphorylation of the somatostatin 2A receptor in human tumors. J Clin Endocrinol Metabol 88: 6073-6079.
24. Lloyd KCK, Wang J, Aurang K, Gronhed P, Coy DH, Walsh JH (1995). Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Am J Physiol 268: G102-G108.
25. Marsh KA, Stamp GW, Kirkland SC (1993). Isolation and characterisation of multiple cell types from a single human colonic carcinoma. J Pathol 170: 441-450.
26. McKeen ES, Feniuk W, Humphrey PPA (1995). Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa. Naunyn-Schmied Arch Pharmacol 352: 402-411.
27. Nunn C, Schoeffter P, Langenegger D, Hoyer D (2003). Functional characterization of the putative somatostatin sst2 receptor antagonist CYN 154806. Naunyn-Schmied Arch Pharmacol 367: 1-9.
28. Sarret P, Botto JM, Vincent JP, Mazella J, Beaudet A (1998). Preferential expression of sst2A over sst2B somatostatin receptor splice variant in rat brain and pituitary. Neuroendocrinology 68: 37-43.
29. Schindler M, Humphrey PPA (1999). Differential distribution of somatostatin sst2 receptor splice variants in rat gastric mucosa. Cell Tissue Res 297: 163-168.
30. 2(b) receptor splice variant. Br J Pharmacol 125: 209-217.
31. Schultzberg M, Hökfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M et al. (1980). Distribution of peptide- and catecholamine-containing neurons in the gastrointestinal tract of rat and guinea-pig. Neuroscience 5: 689-744.
32. Schulz S, Handel M, Schreff M, Schmidt H, Höllt V (2000). Localisation of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies. J Physiol 94: 259-264.
33. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S (1997). Somatostatin receptor subtype specificity in human fetal pituitary cultures, differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99: 789-798.
34. Siehler S, Hoyer D (1999a). Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgS binding. Naunyn-Schmied Arch Pharmacol 360: 500-509.
35. Siehler S, Hoyer D (1999b). Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity. Naunyn-Schmied Arch Pharmacol 360: 510-521.
36. 5 receptors. Eur J Pharmacol 348: 311-320.
37. Siehler S, Seuwen K, Hoyer D (1999). Characterisation of recombinant somatostatin receptors. 1. Radioligand binding studies. Naunyn-Schmied Arch Pharmacol 360: 488-499.
38. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Höllt V, Schulz S (2004). Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279: 21374-21382.
39. Vanetti M, Vogt G, Höllt V (1993). The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitisation. FEBS Lett 331: 260-266.
40. Warhurst G, Higgs NB, Fakhoury H, Warhurst AC, Garde J, Coy DH (1996). Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colon. Gastroenterology 111: 325-333.
41. Weckbecker G, Lewis I, Albert R, Schmid HA, Hoyer D, Bruns C (2003). Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Disc 2: 999-1017.
42. 5 receptor. Br J Pharmacol 118: 445-447.
43. Zomerhuis MT, Hussain SM, Feelders RA, van der Lely AJ, de Herder WW (2005). Octreotide exerts only acute, but not sustained, effects on MRI enhancement of liver metastases in carcinoid syndrome. Neuroendocrinology 82: 41-48.